Globus Medical, Inc. (NYSE: GMED)

This investigation is for anyone who acquired securities in Globus Medical, Inc. (NYSE: GMED) prior to August 13, 2024.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by telling investors that the Company had proper quality controls in place regarding the manufacture of the Company’s Class II Excelsius GPS (EGPS) surgical robot when the Company lacked proper controls.

On August 13, 2024, the FDA published a warning letter to Globus Medical regarding an inspection of the Company’s Class II Excelsius GPS (EGPS) surgical robot, stating that the inspection revealed that “these devices are adulterated” and are not in conformity quality system regulation requirements. On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Globus Medical, Inc. (NYSE: GMED) prior to August 13, 2024 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.